Table 3.
Performance metrics for primary and secondary variables when comparing the clinical natural language processing system to the gold standard.
| Variable | Precision (95% CI) | Recall (95% CI) | F1 value (95% CI) |
| Asthma (primary variable) | 0.94 (0.90-0.96) | 0.96 (0.94-0.98) | 0.95 (0.92-0.97) |
| Extrinsic asthma | 1.00 (0.93-1.00) | 0.75 (0.63-0.85) | 0.86 (0.75-1.00 ) |
| Bronchodilation test | 0.99 (0.94-1.00) | 0.66 (0.58-0.74) | 0.79 (0.71-0.85) |
| Eosinophils in blood | 0.99 (0.96-1.00) | 0.90 (0.84-0.94) | 0.94 ( 0.90-0.97) |
| Gastroesophageal reflux syndrome | 1.00 (0.98-1.00) | 0.93 (0.88-0.96) | 0.96 (0.93-1.00) |
| Obesity | 1.00 (0.93-1.00) | 0.93 (0.82-0.98) | 0.96 (0.87-1.00) |
| Omalizumab | 1.00 (0.84-1.00) | 0.78 (0.58-0.91) | 0.93 (0.68-1.00) |
| Prick test | 0.95 (0.91-0.98) | 0.90 (0.84-0.94) | 0.92 (0.87-0.96) |
| Salmeterol + fluticasone | 0.98 (0.91-1.00) | 0.53 (0.45-0.61) | 0.96 (0.60-0.76) |
| Total IgEa | 0.64 (0.54-0.74) | 0.63 (0.53-0.72) | 0.64 (0.54-0.73) |
aIgE: immunoglobulin E.